29 results
424B5
PROK
ProKidney Corp.
13 Jun 24
Prospectus supplement for primary offering
7:00am
”) reduced disclosure obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote … on executive compensation or golden parachute arrangements.
In addition, an emerging growth company can take advantage of an extended transition period
424B5
PROK
ProKidney Corp.
10 Jun 24
Prospectus supplement for primary offering
5:13pm
obligations regarding executive compensation, and an exemption from the requirements to obtain a non-binding advisory vote on executive compensation
DEF 14A
zhvon6tao
26 May 23
Definitive proxy
8:00am
424B3
0eewun0t5aahum2u
21 Apr 23
Prospectus supplement
4:18pm
POS AM
cjw95s
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
cccv5wz4nbonasirn
9 Sep 22
Prospectus supplement
5:05pm
8-K
ugly1smoov5eh
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFM14A
gwhb7vzth4k0g9ia4
10 Jun 22
Proxy related to merger
4:54pm
8-K/A
EX-99.1
pl2vnlaq
10 Jun 22
Other Events
4:12pm
PRER14A
hfc cqoamsg3a
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
q4hu482gy5ve z8ndt1
23 Mar 22
Annual report
5:32pm